PMID- 11834061 OWN - NLM STAT- MEDLINE DCOM- 20020222 LR - 20190628 IS - 0003-4975 (Print) IS - 0003-4975 (Linking) VI - 73 IP - 1 DP - 2002 Jan TI - Clinical outcome in patients with 19-mm and 21-mm St. Jude aortic prostheses: comparison at long-term follow-up. PG - 37-43 AB - BACKGROUND: Small-sized prostheses for aortic valve replacement may result in residual left ventricular outflow tract obstruction. Aim of the study was to verify whether implantation of 19-mm versus 21-mm St. Jude Medical standard prostheses (St. Jude Medical, Inc, St. Paul, MN) influences long-term clinical outcome. METHODS: Two hundred twenty-nine patients who underwent aortic valve replacement with 19 mm (group 1, 53 patients) or 21-mm St. Jude Medical standard prostheses (group 2, 176 patients) were included in the study. Mean follow-up of current survivors was 10+/-4 years. RESULTS: Operative mortality was 7.5% in group 1 and 8.5% in group 2. At discharge, an important patient-prosthesis mismatch (effective orifice area index < or = 0.60 cm2/m2) was present in 18% of group 1 versus 5% in group 2 (p = 0.004). Among patients with body surface area less than 1.70 m2, such mismatch was present in 15% of group 1 versus 2% of group 2 (p = 0.008). At last follow-up New York Heart Association (NYHA) functional class (p < 0.001), left ventricular mass reduction (p = 0.02), mean (p = 0.002) and peak transprosthetic gradients (p < 0.001), and effective orifice area index (p = 0.005) were significantly better in group 2. Freedom from sudden death (92%+/-5% vs 99%+/-1%, p = 0.01), valve-related death (84%+/-6% vs 90%+/-5%, p = 0.02), and cardiac events (56%+/-13% vs 86%+/-4%, p = 0.008), were significantly lower in group 1. Effective orifice area index was an independent predictor of late cardiac events. CONCLUSIONS: Although long-term results after aortic valve replacement with small-sized St. Jude Medical standard prostheses are satisfactory, 19-mm valve recipients show a high prevalence of important patient-prosthesis mismatch with less evident functional improvement and higher rate of cardiac events, suggesting a very cautious use of this prosthesis. FAU - Milano, Aldo D AU - Milano AD AD - Divisions of Cardiac Surgery and Cardiology, Cardio-Thoracic Department University of Pisa Medical School, Italy. FAU - De Carlo, Marco AU - De Carlo M FAU - Mecozzi, Gianclaudio AU - Mecozzi G FAU - D'Alfonso, Alessandro AU - D'Alfonso A FAU - Scioti, Giovanni AU - Scioti G FAU - Nardi, Carmela AU - Nardi C FAU - Bortolotti, Uberto AU - Bortolotti U LA - eng PT - Comparative Study PT - Journal Article PL - Netherlands TA - Ann Thorac Surg JT - The Annals of thoracic surgery JID - 15030100R SB - IM MH - Aged MH - Aortic Valve Stenosis/diagnostic imaging/*surgery MH - Echocardiography, Doppler MH - Female MH - Follow-Up Studies MH - *Heart Valve Prosthesis MH - *Heart Valve Prosthesis Implantation/adverse effects MH - Humans MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Proportional Hazards Models MH - Prosthesis Design MH - Treatment Outcome EDAT- 2002/02/09 10:00 MHDA- 2002/02/23 10:01 CRDT- 2002/02/09 10:00 PHST- 2002/02/09 10:00 [pubmed] PHST- 2002/02/23 10:01 [medline] PHST- 2002/02/09 10:00 [entrez] AID - S0003-4975(01)03306-9 [pii] AID - 10.1016/s0003-4975(01)03306-9 [doi] PST - ppublish SO - Ann Thorac Surg. 2002 Jan;73(1):37-43. doi: 10.1016/s0003-4975(01)03306-9.